Cell Impact AB (publ) (ICL)
XHAN
0.00260
+0.0012 (+85.71%)
Real-time Data
06:00 AM
Day's Range
0.002600.00260
52 wk Range
0.0001000.0500
Financial Statements - ICL - Cell Impact AB (publ)
Revenue
5.57M▲ 58.4%
Net Income
-131.98M▼ 1294.8%Net Margin -2369.6%
EBITDA
-54.67M▼ 772.5%
Free Cash Flow
-47.29M▼ 554.8%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Sales | 5.57M | 3.51M |
| Cost of Goods | 10.65M | 3M |
| Gross Profit | -5.08M | 510.27K |
 Operating Expense | - | - |
| Operating Income | -127.91M | -9.32M |
| Non-Operating Interest | - | - |
| Other Income Expense | - | - |
| Pre Tax Income | -131.97M | -9.45M |
| Income Tax | 5K | 8K |
| Net Income | -131.98M | -9.46M |
| EPS Basic | -0.5621 | -0.924851 |
| EPS Diluted | -0.5621 | -0.924851 |
| Basic Shares Outstanding | 234.62M | 10.07M |
| Diluted Shares Outstanding | 234.62M | 10.07M |
| Ebit | -127.56M | -9.21M |
| Ebitda | -54.67M | -6.26M |
| Net Income Continuous Operations | -127.91M | -9.32M |
| Minority Interests | - | - |
| Preferred Stock Dividends | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
